The FDA issued safety announcements for Gilenya and Lemtrada in November 2018. These announcements led to changes to the prescribing information for both drugs.
The prescribing information for Ocrevus was updated to provide more detail on the recommended timing of vaccinations prior to starting Ocrevus and the safety and effectiveness of vaccinations after Ocrevus administration.
Read the updated prescribing information for Gilenya, Lemtrada and Ocrevus.